TY  - BOOK
AU  - AlSamman, Mohd Amer
TI  - Adequacy Rate of Magnesium Citrate Bowel Preparation in a Large Retrospective Cohort
SN  - 0363-7913
PY  - 2022///
KW  - *Cathartics
KW  - *Organometallic Compounds
KW  - Cathartics/tu [Therapeutic Use]
KW  - Citric Acid/tu [Therapeutic Use]
KW  - Humans
KW  - Organometallic Compounds/tu [Therapeutic Use]
KW  - Retrospective Studies
KW  - Gastroenterology Fellowship
KW  - MedStar Georgetown University Hospital/MedStar Washington Hospital Center
KW  - Journal Article
N2  - CONCLUSION: MC bowel preparation is adequate, well tolerated, and inexpensive. In a large retrospective analysis, it compares favorably to other preparations; INTRODUCTION: Magnesium Citrate (MC) is not FDA approved as a colonoscopy preparation. Advantages include low cost, small volume and accessibility without prescription. We retrospectively evaluated bowel preparations used in a private gastroenterology practice. The sample size is the largest for any similar studies (n =19,173); METHODS: Electronic Medical Records were queried for colonoscopies between 2010-2016. Bowel preps, indications (screening vs. other) and preparation adequacy were all recorded. Adequacy rates were calculated and compared using generalized linear modeling. Data were analyzed using SAS; RESULTS: The most common prep used was MC 2 bottles; screening (n=6,064, with 98.94% adequacy) and non-screening (n=3,251, with 99.29% adequacy), followed by MC 3 bottles; screening (n=2,757 with 90.35% adequacy), and non-screening (n=1,925 with 92.92% adequacy)
ER  -